Severe asthma: oral corticosteroid alternatives and the need for optimal referral pathways

Cost-effectiveness and comparative effectiveness of biologic therapy for asthma

(2019) William C. Anderson et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

The Effectiveness and Value of Biologic Therapies for the Treatment of Uncontrolled Asthma

(2019) Jeffrey A. Tice et al.   Journal of Managed Care & Specialty Pharmacy

Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management

(2019) Eugene R Bleecker et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: the COSMEX Study

(2019) Sandhya Khurana et al.   CLINICAL THERAPEUTICS

Characterizing patients with asthma who received Global Initiative for Asthma steps 4‐5 therapy and managed in a specialty care setting

(2018) Brian Stone et al.   ALLERGY AND ASTHMA PROCEEDINGS

Asthma control, lung function, symptoms, and corticosteroid sparing after omalizumab initiation in patients with allergic asthma

(2018) Dominic Pilon et al.   ALLERGY AND ASTHMA PROCEEDINGS

Combined value of exhaled nitric oxide and blood eosinophils in chronic airway disease: the Copenhagen General Population Study

(2018) Yunus Çolak et al.   EUROPEAN RESPIRATORY JOURNAL

Oral corticosteroid exposure and adverse effects in asthmatic patients

(2018) Patrick W. Sullivan et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Prospective Open-Label Study of 48-Week Subcutaneous Administration of Mepolizumab in Japanese Patients with Severe Eosinophilic Asthma

(2018) M Kurosawa et al.   JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

(2018) Klaus F. Rabe et al.   NEW ENGLAND JOURNAL OF MEDICINE

The effect of omalizumab treatment on severe allergic asthma and allergic comorbidities: real-life experience from the Czech Anti-IgE Registry

(2018) Beáta Hutyrová et al.   Postepy Dermatologii i Alergologii

Therapeutic Effect of Omalizumab in Severe Asthma: A Real-World Study in Korea

(2018) Ji-Ho Lee et al.   Allergy Asthma & Immunology Research

Effectiveness and safety of omalizumab in severe, persistent IgE-mediated asthma in pediatric and adult patients: a real-world observational study in Egyptian population

(2018) Hesham N. Tarraf et al.   JOURNAL OF ASTHMA

Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study

(2018) Corrado Pelaia et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Biologic treatment eligibility for real-world patients with severe asthma: The IDEAL study

(2017) Frank C. Albers et al.   JOURNAL OF ASTHMA

Omalizumab in non-allergic Asthma: A report of 13 cases

(2017) Zeynep Çelebi Sözener et al.   JOURNAL OF ASTHMA

Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma

(2017) Parameswaran Nair et al.   NEW ENGLAND JOURNAL OF MEDICINE

The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study

(2017) Mohit Bhutani et al.   PLoS One

Measures to reduce maintenance therapy with oral corticosteroid in adults with severe asthma

(2016) Vivi Q. Nguyen et al.   ALLERGY AND ASTHMA PROCEEDINGS

Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

(2016) P. G. Gibson et al.   INTERNAL MEDICINE JOURNAL

Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry

(2016) Joan Sweeney et al.   THORAX

Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)

(2016) Robert M Niven et al.   BMJ Open

AZALEA Trial Highlights Antibiotic Overuse in Acute Asthma Attacks

(2016) Guy G. Brusselle et al.   JAMA Internal Medicine

Improving the diagnosis of eosinophilic asthma

(2016) Hanneke Coumou et al.   Expert Review of Respiratory Medicine

Severe asthma: Epidemiology, burden of illness, and heterogeneity

(2015) David M. Lang   ALLERGY AND ASTHMA PROCEEDINGS

Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort

(2015) Dominick E. Shaw et al.   EUROPEAN RESPIRATORY JOURNAL

The prevalence of severe refractory asthma

(2015) Pieter-Paul W. Hekking et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis

(2015) Leonie H. A. Broersen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Risk factors for death in patients with severe asthma

(2014) Andréia Guedes Oliva Fernandes et al.   Jornal Brasileiro de Pneumologia

Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

(2014) Elisabeth H. Bel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR)

(2014) F. Schleich et al.   RESPIRATORY MEDICINE

The real-life clinical effects of 52 weeks of omalizumab therapy for severe persistent allergic asthma

(2014) Caroline Gouder et al.   International Journal of Clinical Pharmacy

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

(2013) K. F. Chung et al.   EUROPEAN RESPIRATORY JOURNAL

Effectiveness of Omalizumab in Severe Allergic Asthma: A Retrospective UK Real-World Study

(2013) Neil Barnes et al.   JOURNAL OF ASTHMA

A study into efficacy of omalizumab therapy in patients with severe persistent allergic asthma at a tertiary referral centre for asthma in Ireland

(2013) A. Subramaniam et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma

(2012) Marie-Hélène Lafeuille et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry: Table 1

(2012) Joan Sweeney et al.   THORAX

Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review

(2011) Evelyn Sarnes et al.   CLINICAL THERAPEUTICS

Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients

(2011) Zenon Siergiejko et al.   CURRENT MEDICAL RESEARCH AND OPINION

Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma

(2011) G. Pelaia et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Therapy with omalizumab for patients with severe allergic asthma improves asthma control and reduces overall healthcare costs

(2011) R. W. Costello et al.   IRISH JOURNAL OF MEDICAL SCIENCE

Omalizumab Reduces Corticosteroid Use in Patients with Severe Allergic Asthma: Real-Life Experience in Israel

(2011) Menachem Rottem   JOURNAL OF ASTHMA

Omalizumab in the management of oral corticosteroid-dependent IGE-mediated asthma patients

(2010) Christian Domingo et al.   CURRENT MEDICAL RESEARCH AND OPINION

Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: Real-life data

(2010) M. Molimard et al.   RESPIRATORY MEDICINE

Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI)

(2010) E. H. Bel et al.   THORAX

The Impact of Uncontrolled Asthma on Absenteeism and Health-Related Quality of Life

(2009) Bonnie B. Dean et al.   JOURNAL OF ASTHMA

The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use

(2009) Stephanie C. Manson et al.   RESPIRATORY MEDICINE

Economic burden of asthma: a systematic review

(2009) Katayoun Bahadori et al.   BMC Pulmonary Medicine

Effectiveness of omalizumab (Xolair®) in the first patients treated in real-life practice in France

(2007) Mathieu Molimard et al.   RESPIRATORY MEDICINE